Lisa R. Reidy

Lisa counsels both U.S. and foreign issuers and investment banks on a broad range of corporate law matters, including corporate governance, securities regulation, securities offerings, mergers and acquisitions and other major corporate transactions. Her experience as a corporate secretary has positioned her as a trusted advisor to senior executive officers, public company boards of directors, and board committees.

Lisa’s commercially focused and collaborative approach has been instrumental in helping companies achieve their business goals.

She regularly advises U.S. and foreign issuers on the following matters:

• Initial listings on the New York Stock Exchange (NYSE), the NYSE American, and the Nasdaq Stock Market (NASDAQ);
• Securities and Exchange Commission (SEC) reporting and disclosure, including Forms 10-K, 10-Q, 8-K, proxy statements, and Sections 13 and 16 compliance for domestic issuers, and Forms 20-F, 40-F, and 6-K for foreign issuers; and
• Corporate governance requirements under U.S. federal securities laws and exchange rules.

Lisa also represents U.S. and foreign issuers in a broad range of public offerings of equity and debt securities, including initial public offerings (IPOs), follow-on public offerings and secondary resale offerings. She advises foreign issuers on financings under the U.S.-Canada Multijurisdictional Disclosure System (MJDS), other cross-border public offerings, and U.S.-foreign private placements.

Lisa works with clients across a variety of industries, such as life sciences, technology, energy and renewables, mining, and financial services.

• Advised a Delaware financial technology company in its “Up-C” reorganization transactions, initial public offering of Class A common stock for gross proceeds of $1.01 billion, listing on NASDAQ, and its SEC reporting obligations.
• Counseled a Canadian specialty pharmaceutical company in its initial public offering of common shares in the U.S, for gross proceeds of approximately $72.5 million and listing on NASDAQ, its SEC reporting obligations, and acquisition for approximately $635 million in cash.
• Represented a Canadian specialty pharmaceutical company in its SEC reporting, and capital infusion of $350 million in the form of equity, debt and a credit line and acquisition for approximately $146 million (combined market cap of approximately $400 million) in a U.S. tax inversion transaction.
• Advised a public bank holding company in its acquisition for $445.1 million, a merger that created the largest community banking institution in Virginia with over $7.2 billion in total assets.
• Counseled a UK oil and gas exploration and production company with a focus on Africa, in an underwritten rights issue of ordinary shares in the UK with a concurrent private placement in the U.S. pursuant to Rule 144A, for gross proceeds of approximately $750 million.
• Represented an energy services holding company and its subsidiaries in SEC reporting obligations. Represented subsidiary electric and natural gas utility companies in registered shelf offerings of debt securities valued up to $1.2 billion and $1 billion, respectively, and SEC reporting obligations.
• Advised an energy services holding company and its subsidiaries in SEC reporting obligations. Advised a subsidiary public utility company in a private placement of senior notes in the principal amount of $525 million pursuant to Rule 144A and Regulation S.

• Virginia Super Lawyers, Rising Star, Securities & Corporate Finance (2012-2016)